I seem to recall Marty telling me by phone when I asked him around 2 to 3 years.
I cannot be sure I am quoting him 100% accurately therefore I would suggest to call him and ask him directly.
If I have time in the next few days I may do so, but I would encourage others to also.
What I also recall is the reason for such a short duration is that IIb trials roll into (overlap) with phase III and a reduced endpoint requirement based on Orphan drug designation (to come as part of IND approval) is already agreed with the FDA.
planet
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $225.8K | 931.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 288990 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21838 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |